Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Naomi, Haas"'
Autor:
Bonnie Ky, Daniel Lenihan, Chantal ElAmm, Steven Ewer, Hari K. Narayan, Brian S. Finkelman, Amanda M. Smith, David Hyman, Neeraj Agarwal, James Fang, Anna Catino, Mary Putt, Igor Puzanov, Le Wang, Naomi Haas, Stephen Keefe, Vivek Narayan
Supplemental Table S1. Baseline Patient Characteristics Supplemental Table S2. Univariate Analyses of Association Between Clinical Factors and Early LVEF Change on Sunitinib
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::477b3a9ecb2390085cf13c12effd81ea
https://doi.org/10.1158/1078-0432.22466351
https://doi.org/10.1158/1078-0432.22466351
Autor:
Robert J. Motzer, Eric Jonasch, Neeraj Agarwal, Ajjai Alva, Michael Baine, Kathryn Beckermann, Maria I. Carlo, Toni K. Choueiri, Brian A. Costello, Ithaar H. Derweesh, Arpita Desai, Yasser Ged, Saby George, John L. Gore, Naomi Haas, Steven L. Hancock, Payal Kapur, Christos Kyriakopoulos, Elaine T. Lam, Primo N. Lara, Clayton Lau, Bryan Lewis, David C. Madoff, Brandon Manley, M. Dror Michaelson, Amir Mortazavi, Lakshminarayanan Nandagopal, Elizabeth R. Plimack, Lee Ponsky, Sundhar Ramalingam, Brian Shuch, Zachary L. Smith, Jeffrey Sosman, Mary A. Dwyer, Lisa A. Gurski, Angela Motter
Publikováno v:
J Natl Compr Canc Netw
The NCCN Guidelines for Kidney Cancer focus on the screening, diagnosis, staging, treatment, and management of renal cell carcinoma (RCC). Patients with relapsed or stage IV RCC typically undergo surgery and/or receive systemic therapy. Tumor histolo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::16a62ea8338ad46a0c7e96a711b80439
https://doi.org/10.6004/jnccn.2022.0001
https://doi.org/10.6004/jnccn.2022.0001
Autor:
Naomi Haas, Michael Soulen
Publikováno v:
Journal of Vascular and Interventional Radiology. 34:1089-1091.e1
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0da626f0e09cbcc47a90e5b725404a3a
https://doi.org/10.1016/j.jvir.2023.02.015
https://doi.org/10.1016/j.jvir.2023.02.015
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Robert J, Motzer, Eric, Jonasch, Shawna, Boyle, Maria I, Carlo, Brandon, Manley, Neeraj, Agarwal, Ajjai, Alva, Katy, Beckermann, Toni K, Choueiri, Brian A, Costello, Ithaar H, Derweesh, Arpita, Desai, Saby, George, John L, Gore, Naomi, Haas, Steven L, Hancock, Christos, Kyriakopoulos, Elaine T, Lam, Clayton, Lau, Bryan, Lewis, David C, Madoff, Brittany, McCreery, M Dror, Michaelson, Amir, Mortazavi, Lakshminarayanan, Nandagopal, Phillip M, Pierorazio, Elizabeth R, Plimack, Lee, Ponsky, Sundhar, Ramalingam, Brian, Shuch, Zachary L, Smith, Bradley, Somer, Jeffrey, Sosman, Mary A, Dwyer, Angela D, Motter
Publikováno v:
J Natl Compr Canc Netw
The NCCN Guidelines for Kidney Cancer provide multidisciplinary recommendations for diagnostic workup, staging, and treatment of patients with renal cell carcinoma (RCC). These NCCN Guidelines Insights focus on recent updates to the guidelines, inclu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::f00e81f71e7b9b1c29f15f584099aff0
https://pubmed.ncbi.nlm.nih.gov/32886895
https://pubmed.ncbi.nlm.nih.gov/32886895
Autor:
Patrick A Ott, Anne Hamilton, Amanda Jones, Naomi Haas, Tsiporah Shore, Sandra Liddell, Paul J Christos, L Austin Doyle, Michael Millward, Franco M Muggia, Anna C Pavlick
Publikováno v:
PLoS ONE, Vol 5, Iss 1, p e8714 (2010)
Ixabepilone (BMS-247550), an epothilone B analog, is a microtubule stabilizing agent which has shown activity in several different tumor types and preclinical models in melanoma. In an open label, one-arm, multi-center phase II trial the efficacy and
Externí odkaz:
https://doaj.org/article/bcaa7301c3184c05ad9a4660ad8a3bc0
Autor:
Gary Hudes, Naomi Haas, Gwen Yeslow, Thomas Gillon, Per Olov Gunnarsson, Marianne Ellman, Orjan Nordle, Brigitta Eriksson, Langdon Miller, Laura Cisar, Michael Kopreski, Donatella Viaro, Beryl Hartley-Asp
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 20(4)
PURPOSE: To determine the dose-limiting toxicities, maximum-tolerated dose, and pharmacokinetics of intravenous estramustine phosphate (IV EMP). PATIENTS AND METHODS: A total of 31 patients with hormone-refractory prostate cancer received IV EMP as a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ba77724a130aae07ae1009b7d37dd6f4
https://pubmed.ncbi.nlm.nih.gov/11844837
https://pubmed.ncbi.nlm.nih.gov/11844837